FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800333829> ?p ?o ?g. }

• W2800333829 endingPage "1024" @default.
• W2800333829 startingPage "1013" @default.
• W2800333829 abstract "Therapeutic outcome for the treatment of glioma was often limited due to the non-targeted nature of drugs and the physiological barriers, including the blood-brain barrier (BBB) and the blood-brain tumor barrier (BBTB). An ideal glioma-targeted delivery system must be sufficiently potent to cross the BBB and BBTB and then target glioma cells with adequate optimized physiochemical properties and biocompatibility. However, it is an enormous challenge to the researchers to engineer the above-mentioned features into a single nanocarrier particle. New frontiers in nanomedicine are advancing the research of new biomaterials. In this study, we demonstrate a strategy for glioma targeting by encapsulating vincristine sulfate (VCR) into a naturally available apoferritin nanocage-based drug delivery system with the modification of GKRK peptide ligand (GKRK-APO). Apoferritin (APO), an endogenous nanosize spherical protein, can specifically bind to brain endothelial cells and glioma cells via interacting with the transferrin receptor 1 (TfR1). GKRK is a peptide ligand of heparan sulfate proteoglycan (HSPG) over-expressed on angiogenesis and glioma, presenting excellent glioma-homing property. By combining the dual-targeting delivery effect of GKRK peptide and parent APO, GKRK-APO displayed higher glioma localization than that of parent APO. After loading with VCR, GKRK-APO showed the most favorable antiglioma effect in vitro and in vivo. These results demonstrated that GKRK-APO is an important potential drug delivery system for glioma-targeted therapy." @default.
• W2800333829 created "2018-05-17" @default.
• W2800333829 creator A5013516483 @default.
• W2800333829 creator A5013653434 @default.
• W2800333829 creator A5016742496 @default.
• W2800333829 creator A5020249985 @default.
• W2800333829 creator A5034205421 @default.
• W2800333829 creator A5041453096 @default.
• W2800333829 creator A5044580026 @default.
• W2800333829 creator A5046598505 @default.
• W2800333829 creator A5048245914 @default.
• W2800333829 creator A5049692788 @default.
• W2800333829 creator A5049988140 @default.
• W2800333829 creator A5053636127 @default.
• W2800333829 creator A5069516330 @default.
• W2800333829 creator A5087774378 @default.
• W2800333829 date "2018-01-01" @default.
• W2800333829 modified "2023-10-16" @default.
• W2800333829 title "Glioma targeting peptide modified apoferritin nanocage" @default.
• W2800333829 cites W1965426853 @default.
• W2800333829 cites W1966125619 @default.
• W2800333829 cites W1966501740 @default.
• W2800333829 cites W1970991791 @default.
• W2800333829 cites W1975051395 @default.
• W2800333829 cites W1976548137 @default.
• W2800333829 cites W1978667678 @default.
• W2800333829 cites W1983573620 @default.
• W2800333829 cites W1995997091 @default.
• W2800333829 cites W1997457707 @default.
• W2800333829 cites W2014100777 @default.
• W2800333829 cites W2017925961 @default.
• W2800333829 cites W2024825549 @default.
• W2800333829 cites W2034350111 @default.
• W2800333829 cites W2051565538 @default.
• W2800333829 cites W2056474820 @default.
• W2800333829 cites W2059598585 @default.
• W2800333829 cites W2063198665 @default.
• W2800333829 cites W2071421467 @default.
• W2800333829 cites W2072050717 @default.
• W2800333829 cites W2075302528 @default.
• W2800333829 cites W2087782895 @default.
• W2800333829 cites W2088564414 @default.
• W2800333829 cites W2091704235 @default.
• W2800333829 cites W2112250158 @default.
• W2800333829 cites W2146404579 @default.
• W2800333829 cites W2164488758 @default.
• W2800333829 cites W2319797080 @default.
• W2800333829 cites W2329277734 @default.
• W2800333829 cites W2336512659 @default.
• W2800333829 cites W2346093878 @default.
• W2800333829 cites W2509180808 @default.
• W2800333829 cites W8614505 @default.
• W2800333829 cites W2072229818 @default.
• W2800333829 doi "https://doi.org/10.1080/10717544.2018.1464082" @default.
• W2800333829 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6058491" @default.
• W2800333829 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29726297" @default.
• W2800333829 hasPublicationYear "2018" @default.
• W2800333829 type Work @default.
• W2800333829 sameAs 2800333829 @default.
• W2800333829 citedByCount "38" @default.
• W2800333829 countsByYear W28003338292018 @default.
• W2800333829 countsByYear W28003338292019 @default.
• W2800333829 countsByYear W28003338292020 @default.
• W2800333829 countsByYear W28003338292021 @default.
• W2800333829 countsByYear W28003338292022 @default.
• W2800333829 countsByYear W28003338292023 @default.
• W2800333829 crossrefType "journal-article" @default.
• W2800333829 hasAuthorship W2800333829A5013516483 @default.
• W2800333829 hasAuthorship W2800333829A5013653434 @default.
• W2800333829 hasAuthorship W2800333829A5016742496 @default.
• W2800333829 hasAuthorship W2800333829A5020249985 @default.
• W2800333829 hasAuthorship W2800333829A5034205421 @default.
• W2800333829 hasAuthorship W2800333829A5041453096 @default.
• W2800333829 hasAuthorship W2800333829A5044580026 @default.
• W2800333829 hasAuthorship W2800333829A5046598505 @default.
• W2800333829 hasAuthorship W2800333829A5048245914 @default.
• W2800333829 hasAuthorship W2800333829A5049692788 @default.
• W2800333829 hasAuthorship W2800333829A5049988140 @default.
• W2800333829 hasAuthorship W2800333829A5053636127 @default.
• W2800333829 hasAuthorship W2800333829A5069516330 @default.
• W2800333829 hasAuthorship W2800333829A5087774378 @default.
• W2800333829 hasBestOaLocation W28003338291 @default.
• W2800333829 hasConcept C126322002 @default.
• W2800333829 hasConcept C126511603 @default.
• W2800333829 hasConcept C128355301 @default.
• W2800333829 hasConcept C15083742 @default.
• W2800333829 hasConcept C150903083 @default.
• W2800333829 hasConcept C155672457 @default.
• W2800333829 hasConcept C161790260 @default.
• W2800333829 hasConcept C171250308 @default.
• W2800333829 hasConcept C18150654 @default.
• W2800333829 hasConcept C185592680 @default.
• W2800333829 hasConcept C192562407 @default.
• W2800333829 hasConcept C207001950 @default.
• W2800333829 hasConcept C22814914 @default.
• W2800333829 hasConcept C2778227246 @default.
• W2800333829 hasConcept C2778402981 @default.
• W2800333829 hasConcept C2779281246 @default.

• next